GFACX
Price
$72.97
Change
-$0.51 (-0.69%)
Updated
Nov 18 closing price
Net Assets
329.73B
MLRMX
Price
$10.01
Change
-$0.11 (-1.09%)
Updated
Nov 18 closing price
Net Assets
13.54B
Interact to see
Advertisement

GFACX vs MLRMX

Header iconGFACX vs MLRMX Comparison
Open Charts GFACX vs MLRMXBanner chart's image
American Funds Growth Fund of Amer C
Price$72.97
Change-$0.51 (-0.69%)
VolumeN/A
Net Assets329.73B
NYLI Winslow Large Cap Growth SIMPLE Cl
Price$10.01
Change-$0.11 (-1.09%)
VolumeN/A
Net Assets13.54B
GFACX vs MLRMX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. MLRMX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and MLRMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 330B vs. MLRMX (13.5B). GFACX (0.00) and MLRMX (0.00) have matching dividends . GFACX was incepted earlier than MLRMX: GFACX (25 years) vs MLRMX (5 years). GFACX (1.36) is less costly to investors than MLRMX (1.20). MLRMX is a more actively managed with annual turnover of: 70.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than MLRMX: GFACX (250) vs MLRMX (1000). GFACX annual gain was more profitable for investors over the last year : 5.07 vs. MLRMX (-8.25). GFACX return over 5 years is better than : 24.08 vs. MLRMX (-14.37).
GFACXMLRMXGFACX / MLRMX
Total Expense Ratio1.361.19114%
Annual Report Gross Expense Ratio1.361.20113%
Fund Existence25 years5 years-
Gain YTD14.44512.346117%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets330B13.5B2,444%
Annual Yield % from dividends0.000.00-
Returns for 1 year5.07-8.25-61%
Returns for 3 years54.8624.50224%
Returns for 5 years24.08-14.37-168%
Returns for 10 years69.66N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FBIOP6.900.21
+3.13%
Fortress Biotech
TLPH1.340.02
+1.52%
Talphera
JANX29.020.30
+1.04%
Janux Therapeutics
MBAV10.580.01
+0.09%
M3 Brigade Acquisition V Corp.
CDE14.38-0.08
-0.55%
Coeur Mining